Company intelligence / Profile preview

Whiterabbit

Redwood City, California, United States

Ownership: Private
Employees: ~67
Development stage: Other

Overview

Whiterabbit has developed and commercialized FDA-cleared (510(k)) software (WRDensity) to assist radiologists in measuring breast density, which improves early and accurate breast cancer detection. Additional products (ACT, WRRisk) aid in increasing patient screening compliance and providing patient-specific risk assessments. ACT has been shown to increase screening volumes by 20-50% year-over-year at partner centers compared to ~1% previously.

Therapeutic areas: Women's HealthOncology
Modalities: DeviceSoftwareArtificial intelligence-enabled screening tool
Industry: Medical Imaging

Partnerships

RadNetMallinckrodt Institute of Radiology at Washington University in St. LouisArterysAmerican College of Radiology

Beyond the preview

Go deeper on Whiterabbit.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Whiterabbit.

Explore the full profile